Clinical Trial Update: Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated the efficacy and safety of APSCTC for treating postoperative pain following third molar extraction; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• APSCTC

Snippet

Sponsor: Apsen Farmaceutica S.A. | Conditions: Postsurgical Pain, Third Molar Extraction | Phase 3 | Status: COMPLETED